Comparative Study of the Abuse Liability of Alprazolam, Lorazepam, Diazepam, Methaqualone, and Placebo
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Subjective effects of two benzodiazepines--alprazolam and lorazepam--were compared with two drugs of known abuse potential--diazepam and methaqualone--and placebo. This double-blind, crossover trial tested 30 casual recreational sedative users in a seminaturalistic setting. Methaqualone was more euphoriant and less sedative than the benzodiazepines. Diazepam and lorazepam were more euphoriant than placebo; alprazolam's euphoriant effect did not differ from these treatments. On other measures of abuse liability the benzodiazepines rated similarly, diazepam rating highest.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“in another study of recreational drug users without physical dependence, alprazolam was found to have less misuse liability than diazepam (Orzack et al., 1988).”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Orzack et al., 1988
In the citing paper
“Interestingly, despite ICU care and administration of beta-blockers and alpha-blockers, the pseudo-pheochromocytoma was only successfully treated by alprazolam re-instatement (Orzack et al., 1988).”
From A Review of Alprazolam Use, Misuse, and Withdrawal (2018) · cites this paper as Orzack et al., 1988
Citations
Cites
Dahlstrom, W. G., Welsh, G. S., & Dahlstrom, L. E. (1972) · University of Minnesota Press eBooks · Cited by 609
Drug preference and mood in humans: Diazepam
Johanson, C. E., & Uhlenhuth, E. H. (1980) · Psychopharmacology · doi:10.1007/bf00433061 · Cited by 207
Assessment of the abuse liability of buspirone in recreational sedative users.
Cole, J. O., Orzack, M. H., Beake, B., Bird, M., & Bar-Tal, Y. (1982) · PubMed · Cited by 142
Self-citationPharmacokinetics and pharmacodynamics of alprazolam after oral and IV administration
Smith, R. B., Kroboth, P. D., VanderLugt, J. T., Phillips, J. P., & Juhl, R. P. (1984) · Psychopharmacology · doi:10.1007/bf00431449 · Cited by 126
An Overview of Addiction Research Center Inventory Scales (ARCI): An Appendix and Manual of Scales.
Haertzen, C. A. (1974) · Cited by 110
Differential Effects of Diazepam and Pentobarbital on Mood and Behavior
Griffiths, R. R. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790070055007 · Cited by 91
Investigation of the abuse liability of buspirone in alcohol-dependent patients
Griffith, J. D., Jasinski, D. R., Casten, G. P., & McKinney, G. R. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90329-3 · Cited by 88
Abuse liability assessment in human subjects
Jasinski, D. R., Johnson, R. E., & Henningfield, J. E. (1984) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(84)90415-2 · Cited by 87
Comparative pharmacokinetics and pharmacodynamics of lorazepam, alprazolam and diazepam
Ellinwood, E. H., Heatherly, D. G., Nikaido, A. M., Bjornsson, T. D., & Kilts, C. D. (1985) · Psychopharmacology · doi:10.1007/bf00427897 · Cited by 86
Jaffe, J. H., Ciraulo, D. A., Nies, A., Dixon, R. B., & Monroe, L. L. (1983) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1983.224 · Cited by 66
Research works printed but not linked: 3
- Cole J. O., 1982, J. Clin. Psychiatry, 3, 69
- Cole J. O., 1982, Psychopharmacol. Bull., 18, 87
- Jasinski D. R., 1981, Progr. Rep. Nida Addiction Research Center, 41, 45
Cited by
Benzodiazepine use, abuse, and dependence.
O’Brien, C. P. (2005) · PubMed · Cited by 534
A Review of Alprazolam Use, Misuse, and Withdrawal
Ait-Daoud, N., Hamby, A. S., Sharma, S., & Blevins, D. (2018) · Journal of Addiction Medicine · doi:10.1097/adm.0000000000000350 · Cited by 195
“Interestingly, despite ICU care and administration of beta-blockers and alphablockers, the pseudo-pheochromocytoma was only successfully treated by alprazolam re-instatement (Orzack et al., 1988).”
Benzodiazepine use, misuse, and abuse: A review
Schmitz, A. (2016) · Mental Health Clinician · doi:10.9740/mhc.2016.05.120 · Cited by 186
“Blinded recreational drug users perceived diazepam to be more valuable than equipotent doses of alprazolam and lorazepam.(47) Nevertheless, alprazolam and clonazepam are the two BZDs associated with the most abuse-related ED visits; the rate of alprazolam involvement is more than double that of clonazepam.”
BackgroundTesting the abuse liability of anxiolytic and hypnotic drugs in humans
DEWIT, H., & GRIFFITHS, R. (1991) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(91)90054-3 · Cited by 178
Assessment of abuse liability of stimulant drugs in humans: a methodological survey
Foltin, R. W., & Fischman, M. W. (1991) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(91)90052-z · Cited by 143
Metadata
- Authors
- Orzack, M. H., Friedman, L., Dessain, E., Bird, M., Beake, B., McEachern, J., & Cole, J. O.
- Affiliations
- Harvard University (US)
- ORCID
- Cole, Jonathan O.
- Venue
- International Journal of the Addictions
- Publisher
- Informa UK Limited
- Published
- 1988-01
- Volume
- 23
- Issue
- 5
- Pages
- 449-467
- ISSN
- 0020-773X (ISSN-L)
- OpenAlex
- W2130757029
- Cited by
- 34
- References
- 12
- Citations by year
- 2025: 1 · 2024: 1 · 2022: 2 · 2020: 1 · 2017: 1 · 2016: 3 · 2015: 1 · 2012: 1
- FWCI
- 4.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of the Addictions (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA-02349)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- abuse liability, benzodiazepines, alprazolam, lorazepam, diazepam, methaqualone, euphoria, sedation, subjective drug effects
- MeSH terms
- Adolescent, Adult, Alprazolam, Arousal, Diazepam, Euphoria, Female, Humans, Lorazepam, Male, Methaqualone, Risk Factors, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparative Study of the Abuse Liability of Alprazolam, Lorazepam, Diazepam, Methaqualone, and Placebo. https://app.cochat.ai/papers/10.3109/10826088809039211
- The paper
- Orzack, M. H., Friedman, L., Dessain, E., Bird, M., Beake, B., McEachern, J., & Cole, J. O. (1988). Comparative Study of the Abuse Liability of Alprazolam, Lorazepam, Diazepam, Methaqualone, and Placebo. International Journal of the Addictions. https://doi.org/10.3109/10826088809039211
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.